Clinical Trial Update: A Second Psilocybin Group Therapy for the Treatment of Cancer-Related Anxiety in Partial Responders With Metastatic Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial update examining second psilocybin-assisted group therapy for cancer-related anxiety in partial responders with metastatic cancer. The study has c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies
• Malignant Solid Tumors

Drugs mentioned

• Psilocybin (psilocybin)

Snippet

Sponsor: University of Washington | Conditions: Hematopoietic and Lymphatic System Neoplasm, Metastatic Malignant Solid Neoplasm | Phase 1 | Status: COMPLETED